Latest News
Conference Coverage
Diabetes from checkpoint inhibitors probably means lifelong insulin
CHICAGO – In the largest case series to date, almost all patients remained on insulin at a median follow-up of 44 weeks, even after stopping ICIs...
Feature
Patient advocacy groups take in millions from drugmakers. Is there a payback?
KHN launches “Pre$cription for Power,” a groundbreaking database to expose Big Pharma’s ties to patient groups.
From the Journals
Health IT ‘under-users’ outnumber ‘super-users’
“Those relying on the EHR as a vehicle for intervention may be hindered by the technological capacity of ambulatory care partners.”
Daily News Podcast
MDedge Daily News: Antibiotic resistance leads to ‘nightmare’ bacteria
And Medicare formulary changes could be on the way.
Conference Coverage
Statins, ACE inhibitors linked to fetal cardiac anomalies
ORLANDO – First-trimester statin or ACE inhibitor exposure during pregnancy each linked with significantly increased fetal cardiac anomalies.
Latest News
Open enrollment 2018: Plan selections down slightly
The health insurance exchanges saw a 3.3% drop in total enrollees from 2017.
Conference Coverage
Clearer picture emerging of renal impact of SGLT2s
It’s true, it’s true, EMPA-REG shows that SGLT2 inhibitors are renal protective in type 2 diabetes.
Conference Coverage
VIDEO: Poorer cardiometabolic health seen in men with low sperm count
The cardiometabolic derangement was seen even in men with normal testosterone levels.
Daily News Podcast
MDedge Daily News: Could gut bacteria trigger lupus?
And acid suppressors in infancy could fuel allergies later on.
From the Journals
Being overweight as a child increases the risk of developing diabetes
Being overweight as a 7-year-old child can increase type 2 diabetes risk, but reducing and stabilizing body weight can reduce this risk.
Conference Coverage
Levothyroxine may increase mortality in older patients
CHICAGO – A thyroid drug may put patients at a higher risk for death.